Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.

Hayhurst KP, Drake RJ, Massie JA, Dunn G, Barnes TR, Jones PB, Lewis SW.

Eur Psychiatry. 2014 Mar;29(3):191-6. doi: 10.1016/j.eurpsy.2013.03.002. Epub 2013 Jun 12.

PMID:
23769325
2.

Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.

Wehmeier PM, Kluge M, Schacht A, Helsberg K, Schreiber W, Schimmelmann BG, Lambert M.

J Psychiatr Res. 2008 Jul;42(8):676-83. Epub 2007 Aug 27.

PMID:
17720192
3.

Predictors of subjective and objective quality of life in outpatients with schizophrenia.

Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.

Psychiatry Clin Neurosci. 2008 Aug;62(4):404-11. doi: 10.1111/j.1440-1819.2008.01818.x.

4.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

5.

Validity of subjective versus objective quality of life assessment in people with schizophrenia.

Hayhurst KP, Massie JA, Dunn G, Lewis SW, Drake RJ.

BMC Psychiatry. 2014 Dec 24;14:365. doi: 10.1186/s12888-014-0365-x.

6.

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.

Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):703-12. Epub 2007 Jan 16.

PMID:
17289237
7.

Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.

Dunayevich E, Sethuraman G, Enerson M, Taylor CC, Lin D.

Schizophr Res. 2006 Sep;86(1-3):300-8. Epub 2006 Jul 24.

PMID:
16860974
8.

[Quality of life in patients with schizophrenia: a study of 100 cases].

Zouari L, Thabet JB, Elloumi Z, Elleuch M, Zouari N, Maâlej M.

Encephale. 2012 Apr;38(2):111-7. doi: 10.1016/j.encep.2011.03.005. Epub 2011 May 25. French.

PMID:
22516268
9.

Quality of life of Chinese schizophrenia outpatients in Hong Kong: relationship to sociodemographic factors and symptomatology.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Aust N Z J Psychiatry. 2007 May;41(5):442-9.

PMID:
17464737
10.

Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia.

Aki H, Tomotake M, Kaneda Y, Iga J, Kinouchi S, Shibuya-Tayoshi S, Tayoshi SY, Motoki I, Moriguchi K, Sumitani S, Yamauchi K, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.

Psychiatry Res. 2008 Feb 28;158(1):19-25. Epub 2007 Dec 21.

PMID:
18160137
11.

Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia.

Adelufosi AO, Ogunwale A, Abayomi O, Mosanya JT.

Psychiatry Res. 2013 Oct 30;209(3):320-5. doi: 10.1016/j.psychres.2012.12.027. Epub 2013 Feb 27.

PMID:
23452754
12.

Quality of life and psychopathology during the course of schizophrenia.

Rocca P, Giugiario M, Montemagni C, Rigazzi C, Rocca G, Bogetto F.

Compr Psychiatry. 2009 Nov-Dec;50(6):542-8. doi: 10.1016/j.comppsych.2008.12.002. Epub 2009 Mar 10.

PMID:
19840592
13.

Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.

Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.

Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.

PMID:
19672133
14.

Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.

Akinsulore A, Aloba OO, Mapayi BM, Oloniniyi IO, Fatoye FO, Makanjuola RO.

Soc Psychiatry Psychiatr Epidemiol. 2014 Aug;49(8):1191-8. doi: 10.1007/s00127-014-0838-8. Epub 2014 Feb 19.

PMID:
24549838
15.

Predictors of quality of life in inpatients with schizophrenia.

Fujimaki K, Morinobu S, Yamashita H, Takahashi T, Yamawaki S.

Psychiatry Res. 2012 May 30;197(3):199-205. doi: 10.1016/j.psychres.2011.10.023. Epub 2012 Feb 26.

PMID:
22370148
16.

Predictive value of symptoms for quality of life in first-episode schizophrenia.

Chugh PK, Rehan HS, Unni KE, Sah RK.

Nord J Psychiatry. 2013 Jun;67(3):153-8. doi: 10.3109/08039488.2012.687768. Epub 2012 May 16.

PMID:
22587635
17.

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study.

Cuyún Carter GB, Milton DR, Ascher-Svanum H, Faries DE.

BMC Psychiatry. 2011 Aug 26;11:143. doi: 10.1186/1471-244X-11-143.

18.

A comparative study on quality of life of patients of schizophrenia with and without depression.

Dan A, Kumar S, Avasthi A, Grover S.

Psychiatry Res. 2011 Sep 30;189(2):185-9. doi: 10.1016/j.psychres.2011.02.017. Epub 2011 Mar 30.

PMID:
21453977
19.

Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study.

Xiang YT, Wang CY, Wang Y, Chiu HF, Zhao JP, Chen Q, Chan SS, Lee EH, Ungvari GS.

Qual Life Res. 2010 Apr;19(3):317-22. doi: 10.1007/s11136-010-9593-9. Epub 2010 Feb 5.

PMID:
20135234
20.

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW.

Arch Gen Psychiatry. 2006 Oct;63(10):1079-87.

PMID:
17015810

Supplemental Content

Support Center